The Evidence Base
Post
Developing robust methods to support real-world evidence for regulatory decision-making in multiple myeloma: an interview with Ashita Batavia, Johnson & Johnson Innovative Medicine
As part of its real-world evidence (RWE) efforts, the FDA announced four new Cooperative Agreement awards in 2023 to explore the use of real-world data (RWD) for regulatory decision-making, followi...
Register with The Evidence Base for free to access this content
Already have an account? Sign in
By registering with The Evidence Base, you will receive our weekly round-up and other relevant editorial content. You can opt-out at any time. View our privacy policy here.